Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS

Khatri BO;Pelletier J;Kappos L;Hartung HP;COMI , GIANCARLO;Barkhof F;von Rosenstiel P;Meng X;Grinspan A;Hashmonay R;Cohen JA;TRANSFORMS Study Group

2014-01-01